Vanda’s Phase 3 Trial of VQW-765 for Social Anxiety Disorder Fails to Meet Primary Endpoint

The program is now on hold.

Vanda’s Phase 3 Trial of VQW-765 for Social Anxiety Disorder Fails to Meet Primary Endpoint
Photo by Anima Visual on Unsplash
Already have an account? Sign in.